Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Survey.
- Who it may be relevant to
- Registry conditions: Esophageal Cancer, Gastric Cancer. Basic parameters: 18 years — 85 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Belgium
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer. The main question it aims to answer are: * Which diagnostic modality is preferred by patients and the general population? * Which features of the diagnostic test are most detrimental in the decision-making for one or the other modality? * Are geographical differences present in regard to the preference for a diagnostic modality? Participants will be asked to complete a survey of 20-25min, including a brief intake regarding their socio-economic status. This approach will allow us to correct for confounding factors.
Interventions
- Other Survey
Discrete choice survey
Primary outcome measures
- The rate of contribution of diagnostic features to the preference of participants [Time frame: 2 years]
- The percentage differences in preference of participants between geographical regions [Time frame: 2 years]
Secondary outcome measures (2)
- Assess the rate patient-level demographics influence the importance of a test feature, expressed as an odds ratio [Time frame: 2 years]
- Assess the rate of trade-off demonstrated as odds ratio between cancer-related mortality reduction and costs [Time frame: 2 years]
Eligibility criteria
Inclusion criteria
- Individuals >18yo to 75yo (upper age limit of Barrett's surveillance)
- Access to computer or smartphone
- Clear understanding of available languages of the experiment (English, French, Dutch, Spanish, German, Chinese, Japanese)
Exclusion criteria
- Individuals less than 18yo and more than 75yo
- Incarcerated individuals
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Other
Study locations
Belgium · 1 center
- University Hospitals Leuven — Leuven
Identifiers
NCT: NCT06346080 · s68670